Literature DB >> 12774966

Adjuvants in veterinary vaccines: modes of action and adverse effects.

Anna R Spickler1, James A Roth.   

Abstract

Vaccine adjuvants are chemicals, microbial components, or mammalian proteins that enhance the immune response to vaccine antigens. Interest in reducing vaccine-related adverse effects and inducing specific types of immunity has led to the development of numerous new adjuvants. Adjuvants in development or in experimental and commercial vaccines include aluminum salts (alum), oil emulsions, saponins, immune-stimulating complexes (ISCOMs), liposomes, microparticles, nonionic block copolymers, derivatized polysaccharides, cytokines, and a wide variety of bacterial derivatives. The mechanisms of action of these diverse compounds vary, as does their induction of cell-mediated and antibody responses. Factors influencing the selection of an adjuvant include animal species, specific pathogen, vaccine antigen, route of immunization, and type of immunity needed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12774966     DOI: 10.1111/j.1939-1676.2003.tb02448.x

Source DB:  PubMed          Journal:  J Vet Intern Med        ISSN: 0891-6640            Impact factor:   3.333


  28 in total

1.  Mycoplasma hyopneumoniae bacterins and porcine circovirus type 2 (PCV2) infection: induction of postweaning multisystemic wasting syndrome (PMWS) in the gnotobiotic swine model of PCV2-associated disease.

Authors:  Steven Krakowka; John Ellis; Francis McNeilly; Cheryl Waldner; D Michael Rings; Gordon Allan
Journal:  Can Vet J       Date:  2007-07       Impact factor: 1.008

2.  Comparative efficacy of modified-live and inactivated vaccines in boosting responses to bovine respiratory syncytial virus following neonatal mucosal priming of beef calves.

Authors:  John Ellis; Sheryl Gow; Adam Berenik; Stacey Lacoste; Nathan Erickson
Journal:  Can Vet J       Date:  2018-12       Impact factor: 1.008

3.  Evaluation of three adjuvants with respect to both adverse effects and the efficacy of antibody production to the Bm86 protein.

Authors:  Julie Petermann; Romain Bonnefond; Isabelle Mermoud; Dewi Rantoen; Laure Meynard; Christopher Munro; Linda H L Lua; Thomas Hüe
Journal:  Exp Appl Acarol       Date:  2017-07-27       Impact factor: 2.132

4.  Bordetella Colonization Factor A (BcfA) Elicits Protective Immunity against Bordetella bronchiseptica in the Absence of an Additional Adjuvant.

Authors:  Kacy S Yount; Jamie Jennings-Gee; Kyle Caution; Audra R Fullen; Kara N Corps; Sally Quataert; Rajendar Deora; Purnima Dubey
Journal:  Infect Immun       Date:  2019-09-19       Impact factor: 3.441

5.  Immunization with Brucella VirB proteins reduces organ colonization in mice through a Th1-type immune response and elicits a similar immune response in dogs.

Authors:  Cora N Pollak; María Magdalena Wanke; Silvia M Estein; M Victoria Delpino; Norma E Monachesi; Elida A Comercio; Carlos A Fossati; Pablo C Baldi
Journal:  Clin Vaccine Immunol       Date:  2014-12-24

6.  Comparative Study on the Efficacy of MF 59, ISA70 VG, and Nano-Aluminum Hydroxide Adjuvants, Alone and with Nano-Selenium on Humoral Immunity Induced by a Bivalent Newcastle+Avian Influenza Vaccine in Chickens.

Authors:  M Radmehri; A Talebi; A Ameghi Roudsari; S M Mousaviyan; M A J Gholipour; M Taghizadeh
Journal:  Arch Razi Inst       Date:  2021-11-30

7.  Evaluation of Cholera Toxin Adjuvanticity Effect on the Production of Specific Antibodies Induced by Avian Infectious Bronchitis Vaccine in Chickens.

Authors:  A Khastar; H Farzin; M Jamshidian Mojaver
Journal:  Arch Razi Inst       Date:  2022-02-28

Review 8.  Vaccine adjuvants: current challenges and future approaches.

Authors:  Jennifer H Wilson-Welder; Maria P Torres; Matt J Kipper; Surya K Mallapragada; Michael J Wannemuehler; Balaji Narasimhan
Journal:  J Pharm Sci       Date:  2009-04       Impact factor: 3.534

9.  Formulation and delivery of vaccines: Ongoing challenges for animal management.

Authors:  Sameer Sharma; Lyn A Hinds
Journal:  J Pharm Bioallied Sci       Date:  2012-10

10.  Origins of injection-site sarcomas in cats: the possible role of chronic inflammation-a review.

Authors:  Kevin N Woodward
Journal:  ISRN Vet Sci       Date:  2011-04-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.